(Q27654566)

English

Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes

scientific article

Statements

Aleglitazar, a new, potent, and balanced dual PPARalpha/gamma agonist for the treatment of type II diabetes (English)
0 references
Agnes Bénardeau
0 references
Jörg Benz
0 references
Alfred Binggeli
0 references
Denise Blum
0 references
Markus Boehringer
0 references
Uwe Grether
0 references
Hans Hilpert
0 references
Bernd Kuhn
0 references
Hans Peter Märki
0 references
Markus Meyer
0 references
Kurt Püntener
0 references
Susanne Raab
0 references
Armin Ruf
0 references
Daniel Schlatter
0 references
Peter Mohr
0 references
1 May 2009
0 references
19
0 references
9
0 references
2468-73
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit